Inflammation's Role in AGA: Microinflammation Beyond Just Hormones
Affiliate disclosure: This page contains sponsored links. We earn commissions at no extra cost to you. Clinical content is editorially independent.
Histological studies of AGA scalp consistently show lymphocytic infiltrates around miniaturised follicles. The DHT narrative is incomplete — inflammation is an active participant, not a bystander.
The androgenetic alopecia narrative — DHT acts on genetically sensitive follicles via androgen receptors, causing progressive miniaturisation — is accurate but incomplete. Histological studies have consistently documented a microinflammatory component that contributes to the AGA process and may help explain why DHT suppression alone does not produce complete recovery in many patients.
The histological evidence
Scalp biopsies from men with AGA, when processed with appropriate horizontal sectioning and immune staining, reveal perifollicular lymphocytic infiltrates — clusters of CD4+ T cells, mast cells, and dendritic cells surrounding follicular infundibula — in a significant proportion of cases. These infiltrates are not a universal finding (approximately 10–40% of biopsies in various series) but are consistently more common and more severe in biopsies from actively miniaturising and advanced AGA scalp than in non-balding scalp.
The inflammatory infiltrates are located specifically around the upper follicle — the infundibulum and isthmus — rather than the follicle bulb, distinguishing them from the follicle-destructive inflammation of alopecia areata (where the attack targets the bulb). Their anatomical position around the permanent portion of the follicle, including the vicinity of the bulge, suggests that chronic inflammation may compromise bulge stem cell niche integrity over time.
What triggers the microinflammation
The inflammatory trigger in AGA scalp is likely multifactorial:
Malassezia: The commensal scalp yeast produces lipases that metabolise sebum, generating free fatty acids that penetrate into the follicle and trigger keratinocyte inflammatory signalling. Malassezia colonisation is heavier in sebaceous-rich AGA scalp.
Sebum components: Oxidised squalene and other sebum degradation products have direct proinflammatory effects on follicular keratinocytes.
Physical trauma: The mechanical stress on the follicle infundibulum from repeat brushing, styling, and daily physical impact may chronically stress the follicle wall.
The microinflammation-fibrosis link
Perifollicular lymphocytes and mast cells secrete profibrotic mediators — TGF-beta1 in particular — that activate perifollicular fibroblasts to deposit excess collagen. The microinflammatory infiltrates are therefore not merely coincidental to AGA progression; they may be the proximal trigger for the perifollicular fibrosis that limits recovery in advanced disease. Treating the microinflammatory component may thus provide an anti-fibrotic benefit independent of DHT suppression.
Clinical Q&A
Is hair loss an inflammatory condition?
AGA has a significant inflammatory component at the histological level, though it is not typically classified as a primary inflammatory alopecia like alopecia areata. Perifollicular lymphocytic infiltrates are documented in 10–40% of biopsied AGA scalp, and the degree of inflammation correlates with the degree of miniaturisation and fibrosis in some studies.
Does treating inflammation improve hair loss outcomes?
Limited evidence suggests that reducing scalp inflammation — through anti-inflammatory shampoos, ketoconazole's anti-inflammatory effects, or addressing Malassezia overgrowth — may complement DHT-focused treatment. The evidence base for anti-inflammatory adjuncts in AGA is smaller than for standard pharmacological treatment.
Can inflammation cause AGA independently of DHT?
Not according to current evidence — DHT sensitivity appears to be the primary driver and inflammation is secondary or synergistic. However, conditions of severe scalp inflammation (seborrhoeic dermatitis, psoriasis) may accelerate or worsen AGA in susceptible individuals, suggesting the inflammatory component is not trivially small.
References & further reading
- Mahé YF, et al. Androgenetic alopecia and microinflammation. International Journal of Dermatology, 2000.
- Aoi N, et al. Microenvironment of dermal papilla cells in vitro influences the hair follicle regeneration. International Journal of Developmental Biology, 2012.
Get a clinical evaluation
Care Bare Rx
Online consultation with licensed prescribers for hair loss evaluation. Compounded finasteride, minoxidil, and combination formulas prescribed and shipped after a clinical intake review.
Start Your Care Bare Rx Intake Paid linkSesame Care
Direct-booking platform for licensed physician consultations. FDA-approved brand-name and generic hair loss prescriptions at transparent prices, no insurance or membership required.
Browse Sesame Care Providers Paid linkCompounded medications: These preparations are made by a pharmacy for an individual patient and are not FDA-approved for safety, effectiveness, or manufacturing quality. Discuss trade-offs with a licensed prescriber.
Affiliate Disclosure: This site earns commissions on referrals at no extra cost to you. Clinical content is independent.
Medical disclaimer: This article is educational and does not constitute clinical advice, diagnosis, or treatment recommendations. Consult a licensed physician or dermatologist before starting, stopping, or changing any medication or treatment for hair loss.